SCHEMBL23611440

SCHEMBL23611440

CC(C)Oc1ccc(-c2ccc(CNc3cc(-n4cncn4)nc(C(F)(F)F)c3)nc2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ S1PR1 P21453 4/20 0.43
▸ HDAC1 Q13547 5/20 0.42
▸ HDAC6 Q9UBN7 5/20 0.42
▸ KCNH2 Q12809 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ GLA P06280 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HDAC8 Q9BY41 4/20 0.34
▸ P2RX3 P56373 2/20 0.34
▸ PRMT6 Q96LA8 1/20 0.34
▸ PRMT1 Q99873 1/20 0.34
▸ PRMT8 Q9NR22 1/20 0.34
▸ HSD17B10 Q99714 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ KMO O15229 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30062040 1.00 CYP2C19 (0.47) CYP2C19CYP2C9S1PR1HDAC1HDAC6
SCHEMBL23611401 0.88 HDAC1 (0.45) CYP2C19CYP2C9S1PR1HDAC1HDAC6
SCHEMBL30060461 0.88 CYP2C19 (0.47) CYP2C19CYP2C9S1PR1HDAC1HDAC6
SCHEMBL23611499 0.88 CYP2C19 (0.47) CYP2C19CYP2C9S1PR1HDAC1HDAC6
SCHEMBL23611436 0.85 CYP2C19 (0.67) CYP2C19CYP2C9S1PR1HDAC1HDAC6
SCHEMBL30060476 0.85 CYP2C19 (0.67) CYP2C19CYP2C9S1PR1HDAC1HDAC6
SCHEMBL21611985 0.80 CYP2C19 (0.70) CYP2C19CYP2C9S1PR1HDAC1HDAC6
SCHEMBL23611253 0.78 CYP2C19 (0.49) CYP2C19CYP2C9S1PR1HDAC1HDAC6
SCHEMBL30060443 0.78 CYP2C19 (0.49) CYP2C19CYP2C9S1PR1HDAC1HDAC6
SCHEMBL23611365 0.77 SMN1; SMN2 (0.40) CYP2C19CYP2C9HDAC1HDAC6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-A1 NOVEL PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
WO-2021136805-A1 NOVEL PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-07-08 — — WO disclosed
Send feedback